Table 2. Changes of monthly age-standardized hospitalization rates indirectly associated with Dengue, Zika and Chikungunya incidence in municipalities with at least 200 cases of the diseases.
| DENV incidence | ZIKV incidence | CHIKV incidence | |
|---|---|---|---|
| RR1 (95% CrI) | RR1 (95% CrI) | RR1 (95% CrI) | |
| Municipality level 1 | (N = 2,366 municipalities) | (N = 99 municipalities) | (N = 217 municipalities) |
| All causes | 1 (1–1.0001) | 1.0001 (1–1.0002) | 1 (1–1.0001) |
| By chapter | |||
| Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89) | 1.0001 (1–1.0001) | 1.0002 (1–1.0004) | 1.0003 (1.0001–1.0004) |
| Endocrine, nutritional and metabolic diseases (E00-E89) | 1.0001 (1–1.0001) | 1.0003 (1.0001–1.0004) | 1 (0.9999–1.0001) |
| Diseases of the circulatory system (I00-I99) | 1 (1–1) | 1.0001 (1–1.0002) | 1 (1–1.0001) |
| Mental and behavioural disorders (F01-F99) | 1 (1–1) | 1.0003 (1–1.0005) | 0.9999 (0.9997–1) |
| Diseases of the nervous system (G00-G99) | 1 (1–1) | 1.0001 (0.9999–1.0003) | 1 (0.9999–1.0001) |
| Diseases of the eye and adnexa (H00-H59) | 0.9999 (0.9999–1) | 0.9995 (0.9988–1.0001) | 0.9998 (0.9994–1.0003) |
| Diseases of the respiratory system (J00-J99) | 1 (1–1) | 1 (0.9999–1.0002) | 1 (1–1.0001) |
| Diseases of the digestive system (K00-K95) | 1 (1–1) | 1.0001 (1–1.0002) | 1 (0.9999–1) |
| Diseases of the skin and subcutaneous tissue (L00-L99) | 1 (1–1) | 1.0001 (0.9999–1.0003) | 1 (0.9999–1.0001) |
| Diseases of the musculoskeletal system and connective tissue (M00-M99) | 1 (1–1) | 1 (0.9998–1.0002) | 0.9999 (0.9997–1) |
| Diseases of the genitourinary system (N00-N99) | 1 (1–1) | 1.0001 (1–1.0003) | 0.9999 (0.9999–1) |
| By causes | |||
| Diabetes mellitus (E10-E13) | 1 (1–1.0001) | 1.0004 (1.0002–1.0006) | 1.0001 (0.9999–1.0002) |
| Cerebrovascular diseases (I60-I69) | 1 (1–1.0001) | 1.0002 (1–1.0003) | 1 (0.9999–1.0001) |
| Hypertensive diseases (I10-I15) | 1 (1–1.0001) | 1.0002 (0.9999–1.0005) | 0.9999 (0.9997–1.0001) |
| Ischemic heart diseases (I20-I25) | 1.0001 (1–1.0001) | 1 (0.9998–1.0002) | 1 (0.9998–1.0001) |
| Inflammatory diseases of the central nervous system (G00-G09) | 1 (0.9999–1) | 1.0024 (0.9994–1.0052) | 1.0002 (0.9995–1.001) |
| Encephalitis, myelitis and encephalomyelitis; Encephalitis, myelitis and encephalomyelitis in diseases classified elsewhere (G04-G05) | 0.9999 (0.9995–1.0002) | 1.006 (0.9937–1.0181) | 0.9995 (0.9984–1.0007) |
| Sequelae of inflammatory diseases of central nervous system (G09) | 1 (0.9999–1.0001) | 1.0041 (0.9975–1.0096) | 1.0057 (0.998–1.0135) |
| Acute myocarditis (I40) | 0.9987 (0.9968–1.0002) | 0.9995 (0.9796–1.0198) | 1.0068 (0.9927–1.0204) |
| Arthropathies (M00-M25) | 1 (1–1) | 0.9999 (0.9995–1.0002) | 0.9998 (0.9996–1.0001) |
| Inflammatory polyneuropathy (including Guillain-Barré) (G61) | 1.0002 (0.9999–1.0004) | 1.0082 (1.0033–1.0133) | 1.0003 (0.9989–1.0017) |
| Pregnancy with abortive outcome (O00-O08) | 1 (1–1) | 1.0001 (0.9999–1.0003) | 0.9999 (0.9998–1) |
1 Adjusted for the Human Development Index, Gini Index and coverage of the family health Strategy.